Jasper is a former Merck executive who joined Forbion as General Partner for its Growth Opportunities Fund. Before Forbion, Jasper was Senior Vice President and Managing Director at M Ventures (venture arm of Merck) which he joined in 2009. There he led a team of 21 investment professionals and with a fund size of €400 million invested in over 50 portfolio companies spanning biotech, life sciences tools, and tech companies across the investment spectrum. His track record includes the successful exits of Prexton Therapeutics, Epitherapeutics, Galecto, ObsEva, Translate Bio, and F-Star. Jasper holds a PhD in Pharmacy from the University of Groningen, the Netherlands.
Likes
Share It 
